IGY Immune Technologies & Life Sciences Inc. — Form D/A
IGY Immune Technologies & Life Sciences Inc. of THUNDER BAY, A6, a company, filed a Form D amendment with the SEC on 2012-02-22. The offering totals $1.0M, of which $65K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-02-22
- Form: D/A
- Accession: 0001482985-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $65K
- Remaining: $935K
- Minimum investment: $15K
- Investors: 2
- Date of first sale: 2011-09-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-166324
Issuer
- Name: IGY Immune Technologies & Life Sciences Inc.
- CIK: 0001482985
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Incorporated: 2009
- Address: 40 S CUMBERLAND STREET, THUNDER BAY, A6, P7B 2T5
- Phone: 807-343-6013
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Terry Dyck | Director | Thunder Bay, A6 |
| Sharad Mistry | Director | Thunder Bay, A6 |
| Terry Dyck | Executive Officer | Thunder Bay, A6 |
| Sharad Mistry | Executive Officer | Thunder Bay, A6 |
Other filings by this issuer (1)
More